Brief: DSS Discloses Reverse Split of Outstanding, Issues Common Stock

DSS

08/11/2023 13:43

Nov 8 (Reuters) - Dss Inc  DSS.A :
    * DSS INC -  IMPACT BIOMEDICAL EFFECTED A REVERSE STOCK
SPLIT OF
ITS ISSUED AND OUTSTANDING COMMON STOCK BY A RATIO OF 1 FOR 55
    * DSS INC - IMPACT DID NOT EFFECTUATE A REVERSE SPLIT OF ITS
AUTHORIZED CAPITAL STOCK AND NO AMENDMENT TO ARTICLES OF
INCORPORATION OR BYLAWS WAS MADE
    * DSS INC - IMPACT RECEIVED APPROVAL FROM ITS MAJORITY
STOCKHOLDER
AND COMPANY'S BOARD OF DIRECTORS TO EFFECTUATE REVERSE SPLIT

Source text for Eikon:  ID:nGNX9zNxCN 
Further company coverage:  DSS.A 

 ((Reuters.Briefs@thomsonreuters.com;))